Intuitive Surgical’s (ISRG) Hold Rating Reiterated at Canaccord Genuity
Intuitive Surgical, Inc. (NASDAQ:ISRG)‘s stock had its “hold” rating reissued by Canaccord Genuity in a report issued on Tuesday.
Several other equities analysts also recently commented on the stock. Wedbush reissued a “buy” rating on shares of Intuitive Surgical in a research report on Tuesday, October 10th. Morgan Stanley restated an “overweight” rating on shares of Intuitive Surgical in a report on Tuesday, September 5th. Citigroup Inc. restated a “buy” rating and set a $119.78 price target (up from $101.89) on shares of Intuitive Surgical in a report on Monday, July 24th. Wells Fargo & Company restated an “outperform” rating and set a $116.67 price target (up from $111.11) on shares of Intuitive Surgical in a report on Wednesday, July 12th. Finally, Cantor Fitzgerald began coverage on shares of Intuitive Surgical in a report on Thursday, June 29th. They set a “neutral” rating and a $111.11 price target for the company. Five research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $137.11.
Shares of Intuitive Surgical (NASDAQ:ISRG) traded up 2.19% on Tuesday, hitting $377.69. The company’s stock had a trading volume of 720,136 shares. The stock’s 50 day moving average price is $350.65 and its 200 day moving average price is $313.46. Intuitive Surgical has a 52 week low of $203.57 and a 52 week high of $1,094.55. The stock has a market capitalization of $42.09 billion, a P/E ratio of 54.27 and a beta of 0.39.
Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 19th. The medical equipment provider reported $2.77 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.99 by $0.78. The firm had revenue of $806.10 million for the quarter, compared to the consensus estimate of $753.25 million. Intuitive Surgical had a net margin of 30.16% and a return on equity of 18.34%. The business’s quarterly revenue was up 18.0% on a year-over-year basis. During the same period in the prior year, the business posted $2.06 earnings per share. On average, analysts forecast that Intuitive Surgical will post $8.62 earnings per share for the current fiscal year.
In other news, CEO Gary S. Guthart sold 17,975 shares of Intuitive Surgical stock in a transaction dated Thursday, July 27th. The shares were sold at an average price of $937.27, for a total value of $16,847,428.25. Following the completion of the transaction, the chief executive officer now owns 101,798 shares in the company, valued at $95,412,211.46. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Mark J. Meltzer sold 500 shares of Intuitive Surgical stock in a transaction dated Tuesday, September 5th. The stock was sold at an average price of $1,025.00, for a total transaction of $512,500.00. Following the completion of the transaction, the senior vice president now owns 2,796 shares of the company’s stock, valued at approximately $2,865,900. The disclosure for this sale can be found here. Insiders have sold 23,172 shares of company stock valued at $21,923,487 in the last 90 days. 2.20% of the stock is currently owned by corporate insiders.
Several hedge funds have recently added to or reduced their stakes in ISRG. Guardian Life Insurance Co. of America lifted its position in Intuitive Surgical by 2.2% during the first quarter. Guardian Life Insurance Co. of America now owns 142 shares of the medical equipment provider’s stock valued at $109,000 after purchasing an additional 3 shares during the last quarter. ETF Managers Group LLC bought a new stake in Intuitive Surgical during the second quarter valued at approximately $110,000. D. Scott Neal Inc. bought a new stake in Intuitive Surgical during the second quarter valued at approximately $120,000. Harvest Fund Management Co. Ltd bought a new stake in Intuitive Surgical during the second quarter valued at approximately $120,000. Finally, Parallel Advisors LLC lifted its position in Intuitive Surgical by 10.1% during the first quarter. Parallel Advisors LLC now owns 153 shares of the medical equipment provider’s stock valued at $129,000 after purchasing an additional 14 shares during the last quarter. Institutional investors own 31.41% of the company’s stock.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.